Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis

In 2010, porcine circovirus type 1 (PCV1) material was unexpectedly detected in the oral live-attenuated human rotavirus (RV) vaccine, Rotarix™ (GSK Vaccines, Belgium). An initial study (NCT01511133) found no immunologic response against PCV1 in 40 vaccinated infants. As a follow-up, the current stu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2017-01, Vol.13 (1), p.237-244
Hauptverfasser:	Han, Htay Htay, Karkada, Naveen, Jayadeva, Girish, Dubin, Gary
Format:	Artikel
Sprache:	eng
Schlagworte:	Circovirus - immunology Drug Contamination Drug-Related Side Effects and Adverse Reactions - epidemiology Female human rotavirus vaccine Humans Immunoassay - methods Infant Male PCV1 Placebos - administration & dosage porcine circovirus type 1 Research Paper Retrospective Studies Rotarix Rotavirus Vaccines - administration & dosage Rotavirus Vaccines - adverse effects Rotavirus Vaccines - immunology serology Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - adverse effects Vaccines, Attenuated - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!